Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Tunisia flag Tunisia · Delayed Price · Currency is TND
8.50
+0.06 (0.71%)
At close: Apr 3, 2026
Market Cap272.00M +15.6%
Revenue (ttm)153.79M +9.1%
Net Income22.22M +245.3%
EPS0.69 +245.3%
Shares Out32.00M
PE Ratio12.24
Forward PE13.93
Dividend0.57 (6.75%)
Ex-Dividend Daten/a
Volume23,413
Average Volume35,237
Open8.40
Previous Close8.44
Day's Range8.35 - 8.50
52-Week Range7.05 - 10.30
Beta0.11
RSI26.64
Earnings DateMay 4, 2026

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia. [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 572
Stock Exchange Tunis Stock Exchange
Ticker Symbol UMED
Full Company Profile

Financial Performance

In 2024, BVMT:UMED's revenue was 147.68 million, an increase of 8.58% compared to the previous year's 136.00 million. Earnings were 19.37 million, an increase of 249.30%.

Financial Statements